Cargando…
Posaconazole‐induced hypertension in children with cystic fibrosis
Posaconazole is a triazole antifungal with a broad spectrum of activity against moulds including Aspergillus spp. Emerging data suggest posaconazole may be effective in the treatment of allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF). Rarely, posaconazole can cause p...
Autores principales: | Marpole, Rachael, Yeoh, Daniel K., Withers, Adelaide L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8334806/ https://www.ncbi.nlm.nih.gov/pubmed/34377495 http://dx.doi.org/10.1002/rcr2.822 |
Ejemplares similares
-
Posaconazole-Induced Hypertension Masquerading as Congenital Adrenal Hyperplasia in a Child with Cystic Fibrosis
por: Agarwal, Neha, et al.
Publicado: (2020) -
Benefits of reviewing pancreatic function in children with cystic fibrosis
por: Marpole, Rachael, et al.
Publicado: (2022) -
Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis
por: Bentley, Siân, et al.
Publicado: (2021) -
Management Issues for Adolescents with Cystic Fibrosis
por: Withers, Adelaide Lindsay
Publicado: (2012) -
Successful treatment of allergic bronchopulmonary aspergillosis with posaconazole in a child with cystic fibrosis: Case report and review of the literature
por: Yakut, Nurhayat, et al.
Publicado: (2020)